GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Nanoparticles combining platinum and gold act as superefficient catalysts, but chemists have struggled to create them in an industrially useful form. Now Rice University chemists report the development of a polymer-coated version of gold-platinum nanorods, the first catalysts of their kind that can be used in the organic solvents favored by chemical and drug manufacturers. The research is available online in the September 1 issue of Angewandte Chemie International Edition.


During this week's podcast Dr. Eugene Zubarev talks about the new catalyst and where it is used in the drug production process. He also discusses why platinum and gold combinations make excellent catalysts. Dr. Zubarev goes on to describe the procedure for making the platinum and gold nanocatalysts and explains the technique his team relied on to make the gold-platinum nanorods soluble in organic solvents that the industry prefers.

Eugene Zubarev was born and grew up in Astrakhan, Russia. He received his bachelor's degree in chemistry from Moscow State University in 1993 and his and doctorate in chemistry from the Russian Academy of Sciences in 1996. He worked as a research associate at the University of Illinois at Urbana-Champaign and Northwestern University before moving to Iowa State University, where he spent three years as an Assistant Professor of Materials Science and Engineering. In 2005, Zubarev moved to Rice University's Chemistry Department and was promoted to Associate Professor with tenure in July 2009. His current research is focused on molecular self-assembly, synthesis of gold nanocrystals and hybrid materials.

Add a comment

  • Add a comment

  • Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?